{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:48:01Z","timestamp":1789804081304,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Innovative approaches combining regulatory networks (RN) and genomic data are needed to extract biological information for a better understanding of diseases, such as cancer, by improving the identification of entities and thereby leading to potential new therapeutic avenues. In this study, we confronted an automatically generated RN with gene expression profiles (GEP) from a cohort of multiple myeloma (MM) patients and normal individuals using global reasoning on the RN causality to identify key-nodes. We modeled each patient by his or her GEP, the RN and the possible automatically detected repairs needed to establish a coherent flow of the information that explains the logic of the GEP. These repairs could represent cancer mutations leading to GEP variability. With this reasoning, unmeasured protein states can be inferred, and we can simulate the impact of a protein perturbation on the RN behavior to identify therapeutic targets. We showed that JUN\/FOS and FOXM1 activities are altered in almost all MM patients and identified two survival markers for MM patients. Our results suggest that JUN\/FOS-activation has a strong impact on the RN in view of the whole GEP, whereas FOXM1-activation could be an interesting way to perturb an MM subgroup identified by our method.<\/jats:p>","DOI":"10.1038\/s41598-017-09378-9","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T15:33:50Z","timestamp":1502984030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Logic programming reveals alteration of key transcription factors in multiple myeloma"],"prefix":"10.1038","volume":"7","author":[{"given":"Bertrand","family":"Miannay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Minvielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Avet-Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gu\u00e9rin-Charbonnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Gouraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Attal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Facon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Magrangeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carito","family":"Guziolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"9378_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","volume":"12","author":"GJ Morgan","year":"2012","unstructured":"Morgan, G. J., Walker, B. A. & Davies, F. E. The genetic architecture of multiple myeloma. Nature reviews. Cancer 12, 335\u201348 (2012).","journal-title":"Nature reviews. Cancer"},{"key":"9378_CR2","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan, F. et al. The molecular classification of multiple myeloma. Blood 108, 2020\u20132028 (2006).","journal-title":"Blood"},{"key":"9378_CR3","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux, O. et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: A study of the Intergroupe Francophone du My\u00e9lome. Journal of Clinical Oncology 26, 4798\u20134805 (2008).","journal-title":"Journal of Clinical Oncology"},{"key":"9378_CR4","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy","year":"2007","unstructured":"Shaughnessy, J. D. et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109, 2276\u201384 (2007).","journal-title":"Blood"},{"key":"9378_CR5","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","volume":"27","author":"H Avet-Loiseau","year":"2009","unstructured":"Avet-Loiseau, H. et al. Prognostic significance of copy-number alterations in multiple myeloma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27, 4585\u201390 (2009).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"9378_CR6","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","volume":"116","author":"A Broyl","year":"2010","unstructured":"Broyl, A. et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 116, 2543\u201353 (2010).","journal-title":"Blood"},{"key":"9378_CR7","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","volume":"33","author":"BA Walker","year":"2015","unstructured":"Walker, B. A. et al. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 33, 3911\u201320 (2015).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"9378_CR8","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1182\/blood-2014-04-569327","volume":"124","author":"NU Rashid","year":"2014","unstructured":"Rashid, N. U. et al. Differential and limited expression of mutant alleles in multiple myeloma. Blood 124, 3110\u20137 (2014).","journal-title":"Blood"},{"key":"9378_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.1259037","volume":"346","author":"MR Mansour","year":"2014","unstructured":"Mansour, M. R. et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science (New York, NY) 346, 1373\u20137 (2014).","journal-title":"Science (New York, N.Y.)"},{"key":"9378_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"The Gene Ontology Consortium","year":"2000","unstructured":"The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nature Genetics 25, 25\u201329 (2000).","journal-title":"Nature Genetics"},{"key":"9378_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 28, 27\u201330 (2000).","journal-title":"Nucleic acids research"},{"key":"9378_CR12","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2009","unstructured":"Schaefer, C. F. et al. PID: the Pathway Interaction Database. Nucleic acids research 37, D674\u20139 (2009).","journal-title":"Nucleic acids research"},{"key":"9378_CR13","doi-asserted-by":"publisher","first-page":"D1301","DOI":"10.1093\/nar\/gkr1074","volume":"40","author":"T Kelder","year":"2012","unstructured":"Kelder, T. et al. WikiPathways: building research communities on biological pathways. Nucleic acids research 40, D1301\u20137 (2012).","journal-title":"Nucleic acids research"},{"key":"9378_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/bib\/bbn016","volume":"9","author":"E Wingender","year":"2008","unstructured":"Wingender, E. The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Briefings in Bioinformatics 9, 326\u2013332 (2008).","journal-title":"Briefings in Bioinformatics"},{"key":"9378_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bav030","volume":"2015","author":"S Bou\u00e9","year":"2015","unstructured":"Bou\u00e9, S. et al. Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems. Database: the journal of biological databases and curation 2015, bav030 (2015).","journal-title":"Database: the journal of biological databases and curation"},{"key":"9378_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002375","volume":"8","author":"P Khatri","year":"2012","unstructured":"Khatri, P., Sirota, M. & Butte, A. J. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS computational biology 8, e1002375 (2012).","journal-title":"PLoS computational biology"},{"key":"9378_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics (Oxford, England) 25, 1091\u20133 (2009).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"9378_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-340","volume":"14","author":"NL Catlett","year":"2013","unstructured":"Catlett, N. L. et al. Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC bioinformatics 14, 340 (2013).","journal-title":"BMC bioinformatics"},{"key":"9378_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-238","volume":"15","author":"F Martin","year":"2014","unstructured":"Martin, F. et al. Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC bioinformatics 15, 238 (2014).","journal-title":"BMC bioinformatics"},{"key":"9378_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545\u201350 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9378_CR21","doi-asserted-by":"publisher","first-page":"W186","DOI":"10.1093\/nar\/gkm323","volume":"35","author":"C Backes","year":"2007","unstructured":"Backes, C. et al. GeneTrail\u2013advanced gene set enrichment analysis. Nucleic acids research 35, W186\u201392 (2007).","journal-title":"Nucleic acids research"},{"key":"9378_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2010.31","volume":"6","author":"C Lefebvre","year":"2010","unstructured":"Lefebvre, C. et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Molecular systems biology 6, 377 (2010).","journal-title":"Molecular systems biology"},{"key":"9378_CR23","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1093\/bioinformatics\/btl401","volume":"22","author":"SW Kong","year":"2006","unstructured":"Kong, S. W., Pu, W. T. & Park, P. J. A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics (Oxford, England) 22, 2373\u201380 (2006).","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"Suppl 1","key":"9378_CR24","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1093\/bioinformatics\/18.suppl_1.S233","volume":"18","author":"T Ideker","year":"2002","unstructured":"Ideker, T., Ozier, O., Schwikowski, B. & Siegel, A. F. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics (Oxford, England) 18(Suppl 1), S233\u201340 (2002).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"9378_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-282","volume":"13","author":"K Komurov","year":"2012","unstructured":"Komurov, K., Dursun, S., Erdin, S. & Ram, P. T. NetWalker: a contextual network analysis tool for functional genomics. BMC genomics 13, 282 (2012).","journal-title":"BMC genomics"},{"key":"9378_CR26","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/bioinformatics\/btt373","volume":"29","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Topologically inferring risk-active pathways toward precise cancer classification by directed random walk. Bioinformatics (Oxford, England) 29, 2169\u201377 (2013).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"9378_CR27","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/bioinformatics\/btv170","volume":"31","author":"\u00d6N Yavero\u011flu","year":"2015","unstructured":"Yavero\u011flu, \u00d6. N., Milenkovi\u0107, T. & Pr\u017eulj, N. Proper evaluation of alignment-free network comparison methods. Bioinformatics 31, 2697\u20132704 (2015).","journal-title":"Bioinformatics"},{"key":"9378_CR28","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici, S. et al. A systems biology approach for pathway level analysis. Genome research 17, 1537\u201345 (2007).","journal-title":"Genome research"},{"key":"9378_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0733-7","volume":"16","author":"T S","year":"2015","unstructured":"S, T. et al. Extended notions of sign consistency to relate experimental data to signaling and regulatory network topologies. BMC Bioinformatics 16, 345 (2015).","journal-title":"BMC Bioinformatics"},{"key":"9378_CR30","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau, H. et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome. Blood 109, 3489\u201395 (2007).","journal-title":"Blood"},{"key":"9378_CR31","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1182\/blood-2010-01-264796","volume":"115","author":"B Klein","year":"2010","unstructured":"Klein, B. Positioning NK-kappaB in multiple myeloma. Blood 115, 3422\u20134 (2010).","journal-title":"Blood"},{"key":"9378_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2009.87","volume":"5","author":"J Saez-Rodriguez","year":"2009","unstructured":"Saez-Rodriguez, J. et al. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Molecular systems biology 5, 331 (2009).","journal-title":"Molecular systems biology"},{"key":"9378_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0020-7373(87)80053-6","volume":"27","author":"J Quinlan","year":"1987","unstructured":"Quinlan, J. Simplifying decision trees. International Journal of Man-Machine Studies 27, 221\u2013234 (1987).","journal-title":"International Journal of Man-Machine Studies"},{"key":"9378_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests. Machine Learning 45, 5\u201332 (2001).","journal-title":"Machine Learning"},{"key":"9378_CR35","doi-asserted-by":"crossref","unstructured":"Baral, C. Knowledge Representation, Reasoning and Declarative Problem Solving (Cambridge University Press, 2003).","DOI":"10.1017\/CBO9780511543357"},{"key":"9378_CR36","doi-asserted-by":"crossref","unstructured":"Hagberg, A. A., Schult, D. A. & Swart, P. J. Exploring network structure, dynamics, and function using NetworkX. In Proceedings of the 7th Python in Science Conference (SciPy2008), 11\u201315 (2008).","DOI":"10.25080\/TCWV9851"},{"key":"9378_CR37","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2015)."},{"key":"9378_CR38","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/0008-5472.CAN-06-1863","volume":"67","author":"K Podar","year":"2007","unstructured":"Podar, K. et al. Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer research 67, 1680\u20138 (2007).","journal-title":"Cancer research"},{"key":"9378_CR39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V92.1.241.413k28_241_251","volume":"92","author":"FH Xu","year":"1998","unstructured":"Xu, F. H. et al. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK\/SAPK pathway. Blood 92, 241\u2013251 (1998).","journal-title":"Blood"},{"key":"9378_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030215","volume":"7","author":"MN Saha","year":"2012","unstructured":"Saha, M. N. et al. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma. PloS one 7, e30215 (2012).","journal-title":"PloS one"},{"key":"9378_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2009-03-210526","volume":"115","author":"L Chen","year":"2010","unstructured":"Chen, L. et al. Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma. Blood 115, 61\u201370 (2010).","journal-title":"Blood"},{"key":"9378_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.canlet.2013.09.042","volume":"343","author":"F Fan","year":"2014","unstructured":"Fan, F. et al. Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation. Cancer letters 343, 286\u201394 (2014).","journal-title":"Cancer letters"},{"key":"9378_CR43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3324\/haematol.2011.053421","volume":"97","author":"S Uddin","year":"2012","unstructured":"Uddin, S. et al. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma. Haematologica 97, 1092\u2013100 (2012).","journal-title":"Haematologica"},{"key":"9378_CR44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/leu.2015.334","volume":"30","author":"C Gu","year":"2016","unstructured":"Gu, C. et al. FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia 30, 873\u2013882 (2016).","journal-title":"Leukemia"},{"key":"9378_CR45","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/blood-2003-05-1510","volume":"103","author":"K Mahtouk","year":"2004","unstructured":"Mahtouk, K. et al. An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis. Blood 103, 1829\u201337 (2004).","journal-title":"Blood"},{"key":"9378_CR46","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","volume":"24","author":"K Mahtouk","year":"2005","unstructured":"Mahtouk, K. et al. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 24, 3512\u20133524 (2005).","journal-title":"Oncogene"},{"key":"9378_CR47","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.2174\/092986706779026174","volume":"13","author":"JB Johnston","year":"2006","unstructured":"Johnston, J. B. et al. Targeting the EGFR pathway for cancer therapy. Current medicinal chemistry 13, 3483\u20133492 (2006).","journal-title":"Current medicinal chemistry"},{"key":"9378_CR48","first-page":"1367","volume":"25","author":"M Hallek","year":"1997","unstructured":"Hallek, M. et al. Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. Experimental hematology 25, 1367\u201377 (1997).","journal-title":"Experimental hematology"},{"key":"9378_CR49","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2007-10-116590","volume":"112","author":"AML Coluccia","year":"2008","unstructured":"Coluccia, A. M. L. et al. Validation of PDGFRbeta and c-Src tyrosine kinases as tumor\/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib. Blood 112, 1346\u201356 (2008).","journal-title":"Blood"},{"key":"9378_CR50","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1182\/blood.V99.6.2172","volume":"99","author":"H Ishikawa","year":"2002","unstructured":"Ishikawa, H. Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. Blood 99, 2172\u20132178 (2002).","journal-title":"Blood"},{"key":"9378_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/leu.2012.282","volume":"27","author":"H Avet-Loiseau","year":"2013","unstructured":"Avet-Loiseau, H. et al. Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project. Leukemia 27, 711\u2013717 (2013).","journal-title":"Leukemia"},{"key":"9378_CR52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl, R. & Wagner, E. F. AP-1: a double-edged sword in tumorigenesis. Nature reviews. Cancer 3, 859\u201368 (2003).","journal-title":"Nature reviews. Cancer"},{"key":"9378_CR53","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nature Cell Biology 4, E131\u2013E136 (2002).","journal-title":"Nature Cell Biology"},{"key":"9378_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/hmg\/10.7.699","volume":"10","author":"JR Nevins","year":"2001","unstructured":"Nevins, J. R. The Rb\/E2F pathway and cancer. Human molecular genetics 10, 699\u2013703 (2001).","journal-title":"Human molecular genetics"},{"key":"9378_CR55","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-09-0787","volume":"16","author":"ES Knudsen","year":"2010","unstructured":"Knudsen, E. S. & Wang, J. Y. J. Targeting the RB-pathway in cancer therapy. Clinical cancer research: an official journal of the American Association for Cancer Research 16, 1094\u20139 (2010).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09378-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09378-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09378-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:17:03Z","timestamp":1750807023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09378-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9378"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09378-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]},"assertion":[{"value":"29 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9257"}}